Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  HIV Medicine

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1468-1293.2008.00679.xPMID 19187172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment interruption strategies: how great are the risks?

  2008cited by this paper
• Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale

  2008cited by this paper
• HIV and antiretroviral therapy in the brain: neuronal injury and repair

  2008cited by this paper
• Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample.

  2008cited by this paper
• Updated research nosology for HIV-associated neurocognitive disorders

  2007cited by this paper
• Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

  2007cited by this paper
• Spanish Validation of the HIV Dementia Scale in Women

  2007cited by this paper
• Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

  2007cited by this paper
• Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India

  2006cited by this paper
• Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care

  2006cited by this paper
• HIV-Related Neurological Syndromes Reduce Health-Related Quality of Life

  2005cited by this paper
• The International HIV Dementia Scale: a new rapid screening test for HIV dementia

  2005cited by this paper
• HIV Dementia Scale and psychomotor slowing--the best methods in screening for neuro-AIDS.

  2005cited by this paper
• Joint United Nations Programme on HIV/AIDS.

  2004cited by this paper
• The impact of HIV-associated neuropsychological impairment on everyday functioning

  2004cited by this paper
• Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

  2004cited by this paper
• Statistical Methods in Diagnostic Medicine

  2002cited by this paper
• The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.

  2002cited by this paper
• Validity of two scales in identifying HIV-associated dementia.

  1999cited by this paper
• Assessment of Cognitive Function in Asymptomatic HIV-Positive Subjects

  1999cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment

  1998cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

  1998cited by this paper
• Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group.

  1997cited by this paper
• Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder

  1996cited by this paper
• HIV Dementia Scale: a rapid screening test.

  1995cited by this paper
• HIV-1 Associated Dementia: Clinical Features and Pathogenesis

  1995cited by this paper
• Neuropsychological impairment in human immunodeficiency virus‐infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center.

  1994cited by this paper
• Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences

  1994cited by this paper
• A New Bedside Test of Cognition for Patients with HIV Infection

  1993cited by this paper
• Normative Data for a Brief Neuropsychological Screening Battery

  1991cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Analysis of Associated Factors and Construction of Risk Prediction Models for Frailty in Hospitalized Older Adults Living With HIV: Protocol for a Prospective Observational Study.

  2025cites this paper
• Cognitive Screening with the Italian International HIV Dementia Scale in People Living with HIV: A Cross-Sectional Study in the cART Era

  2025cites this paper
• Cognitive Impairment in People Living with HIV and the Impact of Mood: Results from a Cross-Sectional Study

  2024cites this paper
• Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA

  2024cites this paper
• Assessment and Diagnosis of HIV-Associated Dementia

  2023cites this paper
• Selection of cognitive impairment screening tools for longitudinal implementation in an HIV clinical care setting

  2023cites this paper
• Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis

  2022cites this paper
• HIV-Associated Neurocognitive Disorder (HAND): Obstacles to Early Neuropsychological Diagnosis

  2022influential citation
• Primary Care of the Person Living with HIV

  2022cites this paper
• Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control

  2022cites this paper
• Depression and HIV associated neurocognitive disorders among HIV infected adults in rural southwestern Uganda: a cross-sectional quantitative study

  2021cites this paper
• S1-Leitlinie: Diagnostik und Therapie HIV-1-assoziierter neurologischer Erkrankungen

  2021cites this paper
• Frontal Assessment Battery in the evaluation of patients with neurocognitive disorder due to the human immunodeficiency virus.

  2021cites this paper
• International HIV Dementia Scale for HIV-Associated Neurocognitive Disorders: A Systematic Review and Meta-Analysis

  2021cites this paper
• Utility of a Short Neuropsychological Protocol for Detecting HIV-Associated Neurocognitive Disorders in Patients with Asymptomatic HIV-1 Infection

  2021cites this paper
• The influence of major depressive disorders on neurocognitive function among adults living with HIV/AIDS in a regional referral hospital in Dodoma, Tanzania

  2021cites this paper
• Neurological manifestation with special reference to HIV-associated neurocognitive disorder (HAND) among people on anti-retroviral treatment in India.

  2021cites this paper
• Racial differences in scores on the HIV Dementia Scale: mediating effects of literacy and screening utility among Black and White persons with HIV disease

  2021cites this paper
• Frontal Assessment Battery in the evaluation of patients with neurocognitive disorder due to the human immunodeficiency virus.

  2020cites this paper
• Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV

  2020cites this paper
• Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapy

  2020influential citation
• Cribado neurocognitivo en población con virus de inmunodeficiencia adquirida

  2020cites this paper
• Risk Factors of Asymptomatic Neurocognitive Impairment in People Living with HIV in an Indian Cohort

  2020cites this paper
• Prevalence and predictors of HIV-associated Neurocognitive Disorder in Ethiopians

  2020cites this paper
• Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV

  2020cites this paper
• Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.

  2020cites this paper
• Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV

  2020cites this paper
• Balance as an assessment of health-related quality of life in people living with HIV

  2019cites this paper
• Nursing Home Residents by Human Immunodeficiency Virus Status: Characteristics, Dementia Diagnoses, and Antipsychotic Use

  2019cites this paper
• Assessing Risk of HIV-Associated Neurocognitive Disorder

  2019cites this paper
• Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings

  2019cites this paper
• Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders

  2019cites this paper
• HIV-associated neurocognitive disorder.

  2018cites this paper
• Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage

  2018cites this paper
• Voices from Australia– concerns about HIV associated neurocognitive disorder

  2018cites this paper
• The association between symptoms of mental disorders and health risk behaviours in Vietnamese HIV positive outpatients: a cross-sectional study

  2017cites this paper
• Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure

  2017cites this paper
• Head and heart in treated HIV infection

  2017cites this paper
• Prevalence and Correlates of Probable HIV-Associated Dementia in HIV Outpatients in Ho Chi Minh City, Vietnam

  2017cites this paper
• Can patients and their caregivers boost identification of HIV Associated Neurocognitive Disorder (HAND)?

  2017cites this paper
• Subjective memory complaints are associated with poorer cognitive performance in adults with HIV

  2017cites this paper
• HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study

  2017cites this paper
• Assessing the effetiveness of clinical education to reduce the 6 frequency and recurrence of workplace violence

  2017cites this paper
• Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy

  2016cites this paper
• Study to compare performance of International HIV dementia scale ( IHDS ) and Hindi mental state examination ( HMSE ) scale in assessing neurocognitive dysfunction among HIV / AIDS patients on antiretroviral therapy

  2016cites this paper
• Depression and diagnosis of neurocognitive impairment in HIV-positive patients

  2016influential citation
• Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment

  2016cites this paper
• Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic

  2016cites this paper
• Evidence-based perspectives on the implementation of screening for neurocognitive impairment in HIV

  2016influential citation
• A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.

  2016cites this paper
• A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa

  2016influential citation
• The burden of HIV-associated neurocognitive disorder (HAND) in the Asia-Pacific region and recommendations for screening.

  2016cites this paper
• Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE)

  2016cites this paper
• Non-AIDS Morbidity among HIV Patients

  2016cites this paper
• Does the informal caregiver notice HIV associated mild cognitive impairment in people living with HIV?

  2016cites this paper
• The performance of International HIV dementia Scale (IHDS) versus Mini Mental Status Examition Scale (MMSE) in assessment of HIV-associated Neurocognitive Disorders (HAND) among HIV-Infected Tanzanian adults: a Case-Control Study

  2016cites this paper
• Neuropsychological Testing Under the Medical Benefit (for Tennessee Only)

  2016cites this paper
• Validity of the International HIV Dementia Scale as assessed in a socioeconomically underdeveloped region of Southern China: assessing the influence of educational attainment.

  2015cites this paper
• The Montreal Cognitive Assessment

  2015cites this paper
• A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?

  2015cites this paper
• HIV-associated neurocognitive disorders (HAND).

  2015cites this paper
• Primary psychiatric conditions associated with cognitive impairment Delirium Prevalence and severity in HIV infection and AIDS

  2015cites this paper
• Grooved Pegboard for adult employed South Africans: normative data and human immunodeficiency virus associations

  2015cites this paper
• Cognitive impairment in patients with AIDS – prevalence and severity

  2015cites this paper
• Neuropsychological Testing Under the Medical Benefit

  2015cites this paper
• The visuospatial abilities of HIV positive adolescents on antiretroviral treatment in South Africa.

  2014cites this paper
• The Montreal Cognitive Assessment to Screen for Cognitive Impairment in HIV Patients Older Than 60 Years

  2014cites this paper
• HIV Associated Neurocognitive Disorders in the Modern Antiviral Treatment Era: Prevalence, Characteristics, Biomarkers, and Effects of Treatment

  2014cites this paper
• Epidemiology of Psychopathology in HIV

  2014cites this paper
• HIV-associated neurocognitive disorders

  2014cites this paper
• Memory functioning in HIV positive adolescents receiving anti-retroviral treatment.

  2014cites this paper
• A short tool to screen HIV-infected patients for mild neurocognitive disorders – a pilot study

  2014cites this paper
• Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits

  2014cites this paper
• Update on HIV Dementia and HIV-Associated Neurocognitive Disorders

  2014cites this paper
• Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology

  2014cites this paper
• Screening for HIV-related neurocognitive impairment in clinical practice: Challenges and opportunities

  2014cites this paper
• Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.

  2013cites this paper
• A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia Scale

  2013influential citation
• Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER Cohort

  2013cites this paper
• Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide

  2013influential citation
• [HIV-associated neurocognitive disorders].

  2013cites this paper
• Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study

  2013cites this paper
• Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature

  2013cites this paper
• HIV-Associated Neurocognitive Disorders--An issue of Growing Importance.

  2013cites this paper
• Limitations to the identification of HIV‐associated neurocognitive disorders in clinical practice

  2013cites this paper
• Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-Infected Patients After Long-Term Treatment With Combination Antiretroviral Therapy

  2013cites this paper
• Neurologic Complications and Considerations in HIV-Infected Persons

  2013cites this paper
• HIV-associated cognitive disorders: Scientific discoveries through international collaborations in Thailand

  2013cites this paper
• Decision Making Under Risk in Patients with HIV

  2013cites this paper
• HIV-associated cognitive disorders : Scientific discoveries through international collaborations in Thailand

  2013cites this paper
• Human Immunodeficiency Virus Neuropathogenesis

  2013cites this paper
• Reconnaître les changements à l ’ état mental après l ’ ère de l ’ HAART

  2012cites this paper
• Recognizing cognitive and psychiatric changes in the post-highly active antiretroviral therapy era.

  2012cites this paper
• What's in a name? AIDS dementia complex, HIV-associated dementia, HIV-associated neurocognitive disorder or HIV encephalopathy.

  2012cites this paper
• Diagnostic accuracy of the International HIV Dementia Scale and HIV Dementia Scale: A meta-analysis

  2012cites this paper
• Examination of the anti-saccade task as an indicator of cognitive functioning in HIV infected individuals

  2012cites this paper
• Screening for cognitive impairment in human immunodeficiency virus.

  2011influential citation
• Computerized testing augments pencil‐and‐paper tasks in measuring HIV‐associated mild cognitive impairment *

  2011cites this paper
• Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools.

  2011cites this paper
• High-Performance Capillary Electrophoresis for Determining HIV-1 Tat Protein in Neurons

  2011influential citation